This inventor holds 7 USPTO granted patents. Top assignees: Emory University, The Georgia State University Research Foundation, Inc., The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 1999-2014.
Company Filing History:


Years Active: 1999-2014
Title: David S. Stephens: Innovator in Immunology and Pharmaceutical Development
Introduction
David S. Stephens is a prominent inventor based in Stone Mountain, GA (US). He has made significant contributions to the field of immunology and pharmaceutical development, holding a total of 7 patents. His work focuses on innovative solutions for treating inflammatory diseases, particularly those associated with autoimmune conditions.
Latest Patents
Among his latest patents is a groundbreaking invention related to Noscapine and its analogs. This invention pertains to the innate immune pathway and anti-inflammatory molecules with therapeutic properties. It includes compounds and pharmaceutical compositions designed to treat inflammatory diseases, including those linked to autoimmune disorders. Another notable patent involves methods for the recombinant production of an O-acetyltransferase, which is essential for acetylating capsular polysaccharides, particularly those of Serogroup A. This patent also covers immunogenic compositions that comprise the acetylated capsular polysaccharide.
Career Highlights
David S. Stephens has worked with esteemed institutions such as Emory University and the United States Department of Health and Human Services. His career reflects a commitment to advancing medical science and improving therapeutic options for patients suffering from inflammatory diseases.
Collaborations
Throughout his career, David has collaborated with notable colleagues, including Yih-Ling Tzeng and Susu Zughaier. These partnerships have contributed to the success of his research and the development of his patented inventions.
Conclusion
David S. Stephens is a distinguished inventor whose work in immunology and pharmaceutical development has led to significant advancements in treating inflammatory diseases. His innovative patents and collaborations highlight his dedication to improving health outcomes through scientific research.
